A Precision Medicine Model for Targeted NSAID Therapy in Alzheimer's Disease

Keyphrases

• Alzheimer's Disease 100%
• Non-steroidal Anti-inflammatory Drugs (NSAIDs) 100%
• Precision Medicine Models 100%
• Companion Diagnostics 80%
• Precision Medicine 40%
• Naproxen 40%
• Rofecoxib 40%
• Placebo 20%
• Randomized Double-blind 20%
• Blood-based 20%
• Once-daily 20%
• Twice Daily 20%
• Placebo-controlled 20%
• Moderate to Severe 20%
• Oncology 20%
• Proteomics 20%
• Support Vector Machine Analysis 20%
• Therapeutic Benefits 20%
• Alzheimer's Disease Treatment 20%
• Proteomic Assay 20%
• Response Predictors 20%
• NSAID Treatment 20%
• Multiple Interventions 20%
• 25Mg 20%
• Parallel Trials 20%
• Theragnostics 20%

Medicine and Dentistry

• Alzheimer's Disease 100%
• Nonsteroid Antiinflammatory Agent 100%
• Personalized Medicine 100%
• Diagnosis 80%
• Arm 60%
• Placebo 40%
• Proteomics 40%
• Naproxen 40%
• Rofecoxib 40%
• Patient with Alzheimer's Disease 20%
• Group Trial 20%
• Oncology 20%
• Combination Therapy 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Alzheimer's Disease 100%
• Non-Steroidal Anti-Inflammatory Drug 100%
• Placebo 33%
• Naproxen 33%
• Rofecoxib 33%
• Group Trial 16%
• Combination Therapy 16%